Introduction
Oropharyngeal candidiasis (OPC) occurs in a diverse group of patients. Risk factors for OPC include the use of dentures, corticosteroid inhalers, cigarettes, broad-spectrum antibiotics, and immunosuppressive and chemotherapeutic agents. Patients with HIV, diabetes, and iatrogenic or autoimmune-induced dry mouth are also at substantial risk for OPC. This infection is caused primarily by Candida albicans, a ubiquitous polymorphic fungus that is part of the normal microbiota of the gastrointestinal and reproductive tracts of healthy individuals. In order to persistently colonize the oropharynx, C. albicans must adhere to the epithelial cell lining of the oral mucosa while avoiding being killed by host antimicrobial factors. OPC develops when local host defenses are weakened, permitting the fungus to invade and damage oral epithelial cells. The epithelial cells respond to fungal infection by secreting antimicrobial peptides that directly kill the fungus and by releasing pro-inflammatory cytokines that recruit neutrophils to the focus of infection, where they can kill C. albicans and limit the extent of epithelial cell damage [1, 2] . In this Pearl, we summarize recent advances in our knowledge of the pathogenesis of OPC, focusing on fungal-epithelial interactions.
C. albicans Invades, Damages, and Stimulates Oral Epithelial Cells
Although OPC is a superficial fungal infection, it is characterized by invasion of the epithelial cell lining of the oropharynx [3] . C. albicans can invade into oral epithelial cells by two distinct mechanisms, induced endocytosis and active penetration (Fig 1) . During induced endocytosis, C. albicans hyphae express the Als3 [4] and Ssa1 [5] invasins, which bind to E-cadherin and a heterodimer composed of the epidermal growth factor receptor (EGFR) and HER2 on the epithelial cell surface [6] (Fig 1) . These binding events trigger the clathrin-dependent endocytosis machinery and induce epithelial cells to produce pseudopods that engulf the fungus and pull it into the cell. Treatment of mice with a small molecule inhibitor of EGFR/HER2 reduces the severity of OPC, suggesting that induced endocytosis contributes to the pathogenesis of this infection [6] . Additional epithelial cell signaling pathways that are required for maximal endocytosis of C. albicans include the platelet-derived growth factor BB (PDGF BB) and neural precursor-cell-expressed developmentally down-regulated protein 9 (NEDD9) pathways. Activation of these signaling pathways requires C. albicans hyphal formation and expression of the Als3 invasin [7] . The relationship among these pathways and those activated by E-cadherin and EGFR/HER2 has not yet been determined.
Active penetration occurs when elongating C. albicans hyphae physically push their way into the epithelial cell (Fig 1) [8] . While it is likely that both induced endocytosis and active penetration occur during OPC, it has been difficult to determine the role of active penetration a1111111111 a1111111111 a1111111111 a1111111111 a1111111111 in the pathogenesis of OPC because most invasins are hyphal specific. Thus, C. albicans mutants that do not form hyphae also fail to express invasins and, consequently, are defective in both active penetration and induced endocytosis.
C. albicans can also penetrate epithelial cell barriers via a paracellular route by secreting lytic enzymes such as members of the secreted aspartyl proteinase (SAP) family. These proteases degrade E-cadherin and other inter-epithelial cell junctional proteins, enabling the organism to penetrate between epithelial cells [9] (Fig 1) . Recently, it has been found that C. albicans infection also stimulates the activity of epithelial cell calpain, a cysteine protease that degrades E-cadherin. Moreover, calpain activity is dramatically enhanced in epithelial cells that are coinfected with C. albicans and Streptococcus oralis [10] .
When C. albicans invades epithelial cells, it damages them. Epithelial cells in turn respond to C. albicans by secreting proinflammatory cytokines and antimicrobial peptides. Recently, it was discovered that C. albicans-induced epithelial cell damage is mainly caused by candidalysin, a toxin released by the fungus (Fig 1) . Candidalysin is encoded by the hyphal-specific gene ECE1. The protein is cleaved by the Kex2 protease into eight peptides, of which only one permeabilizes epithelial cell membranes, induces epithelial cell damage, and stimulates epithelial cell cytokine secretion. A C. albicans ece1Δ/Δ deletion mutant is defective in damaging and stimulating oral epithelial cells in vitro. Furthermore, it has a greatly attenuated virulence in the mouse model of OPC [11] . Thus, candidalysin and epithelial cell damage play a central role in the pathogenesis of OPC. . These data suggest that oral epithelial cells sense and respond to contact with C. albicans, and that this initial response is subsequently amplified by candidalysin. While EGFR/HER2 and E-cadherin interact with C. albicans hyphae, the epithelial cell receptor(s) that is activated by yeast-phase C. albicans is currently unknown.
Interplay between Epithelial Cell-Derived Antimicrobial Peptides and C. albicans
Host defense peptides (HDPs) represent one of the first lines of defense against invading microbes. Epithelial cells release multiple types of HDPs, including β-defensins and cathelicidins, that either kill or inhibit the growth of C. albicans. Different HDPs have different mechanisms of action, and their targets include the fungal cell membrane and mitochondria [14] . HDPs that are highly expressed during the early stage of OPC in mice include murine β-defensin 1 (mBD1), β-defensin 3 (the homolog of human β-defensin 2), and the alarmins S100A8 and S100A9 [15] . The importance of epithelial cell-derived HDPs in the host defense against OPC is demonstrated by finding that mBD1-deficient mice develop severe OPC, even in the absence of immunosuppression [16] . By contrast, immunocompetent wild-type mice are resistant to OPC, and when orally inoculated with C. albicans, clear the infection within 2-3 days. Mice that are deficient in either IL-17 receptor A (IL-17RA) or IL-17RC fail to up-regulate HDPs in the oral epithelium in response to C. albicans infection and are highly susceptible to OPC [1, 15] . Recently, it was shown that mice with oral epithelial cell specific deletion of IL-17RA have reduced expression of Defb3 (encoding β-defensin 3) in the oral mucosa and increased susceptibility to OPC. This increased susceptibility is phenocopied by deletion of Defb3 [17] . Finally, people with mutations in signal transducer and activator of transcription 3 (STAT3) fail to mount a Th17 response, have significantly reduced salivary β-defensin 2 and histatins, and suffer from chronic mucocutaneous candidiasis [18] . Collectively, these data indicate that the response of oral epithelial cells to C. albicans, especially the production of HDPs, contributes to the host defense against OPC.
When C. albicans colonizes the oral mucosa of healthy individuals and causes OPC in patients, it must be able to withstand HDPs. The fungus has evolved multiple different mechanisms that enable it to evade the deleterious effects of HDPs and persist in the oral cavity [14] . These mechanisms include shedding of the Msb2 mucin, which binds to and inactivates HDPs, and secretion of aspartyl proteases, which break down HDPs [19, 20, 21] (Fig 1) . C. albicans also expresses the Flu1 efflux pump that reduces intracellular HDP levels [22] .
Exposure to HDPs induces a stress response in C. albicans, and susceptibility to HDPs is governed in part by the signaling pathways that are activated in response to these peptides. Activation of the high-osmolarity-glycerol (HOG) pathway enables C. albicans to resist histatin 5 and human β-defensins 2 and 3 [23, 24] . The Ssd1 RNA-binding protein acts in part through the Bcr1 transcription factor to mediate resistance to human β-defensin 2 [25, 26] . Conversely, activation of the Cek1 mitogen-activated protein kinase (MAPK) enhances surface exposure of β-1,3-glucans, elevating the uptake of histatin 5 and increasing sensitivity to this HDP [27] .
Co-infection with C. albicans and Other Microorganisms Influences Virulence during OPC
C. albicans is frequently isolated from the oral cavity in conjunction with other microbial pathogens. In a study of AIDS patients with OPC [28], 107 out of 1,106 episodes of infection (9.7%) were caused by more than one species of Candida. Among the subjects with multispecies OPC, C. albicans plus C. glabrata (68.2%) was the most common co-infection, followed by C. albicans plus C. tropicalis (15.0%) and C. albicans plus C. glabrata plus C. tropicalis (8.4%). These epidemiological data suggest that C. glabrata has unique characteristics that facilitate co-infection with C. albicans.
Silva et al. [29] reported that C. glabrata is unable to invade reconstituted human oral epithelium in vitro and causes minimal epithelial cell damage. A potential explanation for this finding is that C. glabrata grows only as yeast in vivo and does not form hyphae at foci of infection. However, when oral epithelial cells are infected with a mixture of C. glabrata and C. albicans, the C. glabrata cells bind to C. albicans hyphae and are carried deeper into the epithelium, where they cause extensive epithelial cell damage (Fig 1) . It was recently reported that C. glabrata alone is not able to cause disease in a mouse model of OPC. However, when mice are inoculated with a mixture of C. albicans and C. glabrata, they develop more severe disease than mice infected with C. albicans alone [30] . This synergistic infection requires the expression of the Als1 and Als3 adhesins/invasins by the C. albicans hyphae. Multiple C. glabrata adhesins, including Epa8, Epa19, Awp2, Awp7, and CAGL0F00181, mediate adherence to C. albicans hyphae; whether they interact specifically with C. albicans Als1 and/or Als3 remains to be determined [30] . Collectively, these results provide an explanation for the frequent co-isolation of C. glabrata and C. albicans in patients with OPC. Although C. tropicalis can occasionally cause OPC in conjunction with C. albicans, the mechanistic basis for this co-infection is currently unknown.
Co-infection with C. albicans can also augment infection with S. aureus. When mice are immunosuppressed with cortisone acetate and then orally inoculated with S. aureus, the bacteria persist in the oral cavity in relatively low numbers and do not cause detectable disease [31] . However, when mice with OPC due to C. albicans are orally inoculated with S. aureus, the bacteria adhere to the fungal hyphae, which transport the bacteria along with them as they invade into the superficial oral epithelium. Not only does the presence of C. albicans result in higher levels of S. aureus in the oral cavity but it also enables S. aureus to invade the oral mucosa and cause a fatal hematogenously disseminated infection. This pathologic interaction between S. aureus and C. albicans is dependent on Als3; even though an als3Δ/Δ null mutant is still able to cause OPC, S. aureus co-infection does not result in a disseminated staphylococcal infection [31] . Although OPC is not known to be associated with disseminated staphylococcal infection in patients, it is possible that the interaction of S. aureus with C. albicans at other anatomic sites, such as the gastrointestinal tract or peritoneal cavity [32] , might facilitate the development of S. aureus bacteremia.
C. albicans is also known to interact with common oral commensal bacteria. In vitro studies demonstrate that Streptococcus gordonii and C. albicans co-adhere during mixed-species biofilm formation [33] . This interaction is mediated by the S. gordonii cell wall-anchored proteins SspA and SspB and the C. albicans surface proteins Als3, Eap1, and Hwp1. The presence of S. gordonii enhances C. albicans hyphal development and increases biofilm mass [33,34,35]; whether it also augments C. albicans virulence during OPC is currently unknown. Co-infection with Streptococcus mutans also increases C. albicans biofilm formation in vitro. However, Galleria mellonella larvae infected with both organisms have prolonged survival compared to larvae infected with C. albicans alone. This reduction in virulence is likely due to inhibition of fungal hyphal formation by the bacteria [36] . By contrast, Streptococcus oralis both augments C. albicans biofilm formation in vitro and increases virulence during experimental OPC in mice, as manifested by increased size of the oral lesions and greater fungal dissemination to distal organs [37, 38] . These data demonstrate that the interaction of C. albicans with the oral microbiota has the potential to significantly influence the pathogenesis of OPC.
Conclusions and Perspective
The oral epithelium is a critical component of the host defense against OPC. However, C. albicans has evolved multiple strategies to breach the epithelial cell barrier, withstand HDPs, and cause a superficial infection. In mouse models of infection, other microbial pathogens can interact with C. albicans and alter virulence. This pathogenic interaction is undoubtedly relevant to human infection in the case of C. glabrata and streptococci because these organisms are commonly isolated in conjunction with C. albicans. Whether mucosal infection with C. albicans predisposes patients to develop invasive staphylococcal infections is currently unknown but is clearly worthy of investigation. 
